44 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
that demonstrates our commitment to rare diseases and aligns with our growth strategy through partnerships beyond internal research and development,” said … chapter in our collective journey.”
“This acquisition reflects Chiesi Group’s commitment towards patients. Chiesi strives to create a world where
F-1
EX-10.1
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
Capital Management, LP and its affiliates and the investment funds managed or advised by any of the foregoing.
1.15. Backstop Commitment means … the commitment of the Backstop Parties to purchase Unsubscribed Shares as set forth in the Backstop Commitment Agreement.
1.16. Backstop Commitment Agreement
6-K
EX-99.1
AMYT
Amryt Pharma Plc
25 Feb 22
Current report (foreign)
4:05pm
such Borrowing, are Term Loans, Revolving Loans or Swingline Loans, (b) any Commitment, refers to whether such Commitment is a Term Loan Commitment … , a Revolving Credit Commitment or a commitment to make Swingline Loans, (c) any Lender, refers to whether such Lender has a Loan or Commitment of a particular
DRS/A
EX-10.5
AMYT
Amryt Pharma Plc
11 May 20
Draft registration statement (amended)
12:00am
of the Obligations or the performance of any Loan Party’s other duties and obligations under the Loan Documents.
“Commitment” means, as to each Lender, its … such Lender’s name on Schedule 2.01 hereto under the caption “Commitment”. Commitments will terminate once advanced.
“Committed Loan Notice” means a notice
F-1
EX-10.5
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
of the Obligations or the performance of any Loan Party’s other duties and obligations under the Loan Documents.
“Commitment” means, as to each Lender, its … such Lender’s name on Schedule 2.01 hereto under the caption “Commitment”. Commitments will terminate once advanced.
“Committed Loan Notice” means a notice
6-K
EX-99.4
1vrvdil6lc6ude5f
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.2
jltqrpt dv4l0l
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.3
2cd ba16dnr74gd
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
8c3wu2 wrm5husf37
5 May 21
Agreement and Plan of Merger
5:19pm
425
ncuwws8apm 3qd
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.1
lt3rgrp8i6fyjgotzo
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
6-K
EX-99.1
ad6d12p csfg
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
6-K
EX-99.4
jpkc7g cm
11 May 22
Current report (foreign)
4:30pm
6-K
EX-99.1
w59t53
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B3
ta0qn
2 Jun 21
Prospectus supplement
10:10am
424B3
ddvjxcb mzt
2 Jun 21
Prospectus supplement
10:09am
6-K
EX-99.1
g3q1aqo wijjs
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.1
fe8hdx
5 May 21
Agreement and Plan of Merger
5:19pm
DRS/A
EX-10.3
w0344rwg8wfz1m
11 May 20
Draft registration statement (amended)
12:00am